MUTANTS OF HUMAN IL-3
Biologically active polypeptide analogue (A) of human IL-3 comprises a deletion of at least 2 residues compared with mature human IL-3. The deletion comprises an N-terminal deletion of upto 14 residues and/or a C-terminal deletion of upto 18 amino acids. Pref. mutants are the substn. mutants; having...
Gespeichert in:
Hauptverfasser: | , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | VAN LEEN, ROBERT WILLEM DORSSERS, LAMBERTUS CHRISTIAAN JOHANNES |
description | Biologically active polypeptide analogue (A) of human IL-3 comprises a deletion of at least 2 residues compared with mature human IL-3. The deletion comprises an N-terminal deletion of upto 14 residues and/or a C-terminal deletion of upto 18 amino acids. Pref. mutants are the substn. mutants; having following substitution(s); Asp21 Glu22 = Lys21 Arg22, Asp36 = Arg36, Glu43 = Asp44Asp44 = Lys43 Arg44, Arg54 Arg55 = Glu54 Asp55, Asp46= Lys46 or Arg46, Glu50 = Lys50 or Arg 50, Glu59 = Lys59 or Pro59 (alpha-helix breaker), Arg63 Ala64 = Pro63 Gly64, Glu75 = Arg75 or Gly75, Lys79 = Glu79, Arg94 = Pro94, His98 Lys100 Asp 101 = Glu98 Asp100 Gln101, Glu106 = Lys106, Arg108 Arg109 Arg110 = Glu108 Asp109 Glu110, Phe113 Try114 = Ala113 Thr114, Cys16 = Ala16, Cys84 = Ala84 or Cys16 Cys84 = Ala16 Ala84. Also claimed are: (1) a DNA fragment (I) contg. a sequence encoding (A); (2) a cloning vehicle contg. (I); (3) a host cell transformed with the vehicle of (2); (4) a process for obtaining (A); and (5) a monoclonal antibody (MAb) directed against an epitope between residues 29 - 34, of mature human IL-3. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_NZ234869A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>NZ234869A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_NZ234869A3</originalsourceid><addsrcrecordid>eNrjZBD1DQ1x9AsJVvB3U_AI9XX0U_D00TXmYWBNS8wpTuWF0twMcm6uIc4euqkF-fGpxQWJyal5qSXxflFGxiYWZpaOxgQVAADUxx2T</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>MUTANTS OF HUMAN IL-3</title><source>esp@cenet</source><creator>VAN LEEN, ROBERT WILLEM ; DORSSERS, LAMBERTUS CHRISTIAAN JOHANNES</creator><creatorcontrib>VAN LEEN, ROBERT WILLEM ; DORSSERS, LAMBERTUS CHRISTIAAN JOHANNES</creatorcontrib><description>Biologically active polypeptide analogue (A) of human IL-3 comprises a deletion of at least 2 residues compared with mature human IL-3. The deletion comprises an N-terminal deletion of upto 14 residues and/or a C-terminal deletion of upto 18 amino acids. Pref. mutants are the substn. mutants; having following substitution(s); Asp21 Glu22 = Lys21 Arg22, Asp36 = Arg36, Glu43 = Asp44Asp44 = Lys43 Arg44, Arg54 Arg55 = Glu54 Asp55, Asp46= Lys46 or Arg46, Glu50 = Lys50 or Arg 50, Glu59 = Lys59 or Pro59 (alpha-helix breaker), Arg63 Ala64 = Pro63 Gly64, Glu75 = Arg75 or Gly75, Lys79 = Glu79, Arg94 = Pro94, His98 Lys100 Asp 101 = Glu98 Asp100 Gln101, Glu106 = Lys106, Arg108 Arg109 Arg110 = Glu108 Asp109 Glu110, Phe113 Try114 = Ala113 Thr114, Cys16 = Ala16, Cys84 = Ala84 or Cys16 Cys84 = Ala16 Ala84. Also claimed are: (1) a DNA fragment (I) contg. a sequence encoding (A); (2) a cloning vehicle contg. (I); (3) a host cell transformed with the vehicle of (2); (4) a process for obtaining (A); and (5) a monoclonal antibody (MAb) directed against an epitope between residues 29 - 34, of mature human IL-3.</description><edition>5</edition><language>eng</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROCESSES USING MICROORGANISMS ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>1991</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19911223&DB=EPODOC&CC=NZ&NR=234869A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76516</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19911223&DB=EPODOC&CC=NZ&NR=234869A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>VAN LEEN, ROBERT WILLEM</creatorcontrib><creatorcontrib>DORSSERS, LAMBERTUS CHRISTIAAN JOHANNES</creatorcontrib><title>MUTANTS OF HUMAN IL-3</title><description>Biologically active polypeptide analogue (A) of human IL-3 comprises a deletion of at least 2 residues compared with mature human IL-3. The deletion comprises an N-terminal deletion of upto 14 residues and/or a C-terminal deletion of upto 18 amino acids. Pref. mutants are the substn. mutants; having following substitution(s); Asp21 Glu22 = Lys21 Arg22, Asp36 = Arg36, Glu43 = Asp44Asp44 = Lys43 Arg44, Arg54 Arg55 = Glu54 Asp55, Asp46= Lys46 or Arg46, Glu50 = Lys50 or Arg 50, Glu59 = Lys59 or Pro59 (alpha-helix breaker), Arg63 Ala64 = Pro63 Gly64, Glu75 = Arg75 or Gly75, Lys79 = Glu79, Arg94 = Pro94, His98 Lys100 Asp 101 = Glu98 Asp100 Gln101, Glu106 = Lys106, Arg108 Arg109 Arg110 = Glu108 Asp109 Glu110, Phe113 Try114 = Ala113 Thr114, Cys16 = Ala16, Cys84 = Ala84 or Cys16 Cys84 = Ala16 Ala84. Also claimed are: (1) a DNA fragment (I) contg. a sequence encoding (A); (2) a cloning vehicle contg. (I); (3) a host cell transformed with the vehicle of (2); (4) a process for obtaining (A); and (5) a monoclonal antibody (MAb) directed against an epitope between residues 29 - 34, of mature human IL-3.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROCESSES USING MICROORGANISMS</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1991</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZBD1DQ1x9AsJVvB3U_AI9XX0U_D00TXmYWBNS8wpTuWF0twMcm6uIc4euqkF-fGpxQWJyal5qSXxflFGxiYWZpaOxgQVAADUxx2T</recordid><startdate>19911223</startdate><enddate>19911223</enddate><creator>VAN LEEN, ROBERT WILLEM</creator><creator>DORSSERS, LAMBERTUS CHRISTIAAN JOHANNES</creator><scope>EVB</scope></search><sort><creationdate>19911223</creationdate><title>MUTANTS OF HUMAN IL-3</title><author>VAN LEEN, ROBERT WILLEM ; DORSSERS, LAMBERTUS CHRISTIAAN JOHANNES</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_NZ234869A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>1991</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROCESSES USING MICROORGANISMS</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>VAN LEEN, ROBERT WILLEM</creatorcontrib><creatorcontrib>DORSSERS, LAMBERTUS CHRISTIAAN JOHANNES</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>VAN LEEN, ROBERT WILLEM</au><au>DORSSERS, LAMBERTUS CHRISTIAAN JOHANNES</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>MUTANTS OF HUMAN IL-3</title><date>1991-12-23</date><risdate>1991</risdate><abstract>Biologically active polypeptide analogue (A) of human IL-3 comprises a deletion of at least 2 residues compared with mature human IL-3. The deletion comprises an N-terminal deletion of upto 14 residues and/or a C-terminal deletion of upto 18 amino acids. Pref. mutants are the substn. mutants; having following substitution(s); Asp21 Glu22 = Lys21 Arg22, Asp36 = Arg36, Glu43 = Asp44Asp44 = Lys43 Arg44, Arg54 Arg55 = Glu54 Asp55, Asp46= Lys46 or Arg46, Glu50 = Lys50 or Arg 50, Glu59 = Lys59 or Pro59 (alpha-helix breaker), Arg63 Ala64 = Pro63 Gly64, Glu75 = Arg75 or Gly75, Lys79 = Glu79, Arg94 = Pro94, His98 Lys100 Asp 101 = Glu98 Asp100 Gln101, Glu106 = Lys106, Arg108 Arg109 Arg110 = Glu108 Asp109 Glu110, Phe113 Try114 = Ala113 Thr114, Cys16 = Ala16, Cys84 = Ala84 or Cys16 Cys84 = Ala16 Ala84. Also claimed are: (1) a DNA fragment (I) contg. a sequence encoding (A); (2) a cloning vehicle contg. (I); (3) a host cell transformed with the vehicle of (2); (4) a process for obtaining (A); and (5) a monoclonal antibody (MAb) directed against an epitope between residues 29 - 34, of mature human IL-3.</abstract><edition>5</edition><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_epo_espacenet_NZ234869A |
source | esp@cenet |
subjects | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROCESSES USING MICROORGANISMS PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE |
title | MUTANTS OF HUMAN IL-3 |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-19T11%3A37%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=VAN%20LEEN,%20ROBERT%20WILLEM&rft.date=1991-12-23&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ENZ234869A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |